These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22572736)

  • 1. Evaluating rare variants under two-stage design.
    Li Q; Pan D; Yue W; Gao Y; Yu K
    J Hum Genet; 2012 Jun; 57(6):352-7. PubMed ID: 22572736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidden Markov models for controlling false discovery rate in genome-wide association analysis.
    Wei Z
    Methods Mol Biol; 2012; 802():337-44. PubMed ID: 22130891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new expectation-maximization statistical test for case-control association studies considering rare variants obtained by high-throughput sequencing.
    Gordon D; Finch SJ; De La Vega FM
    Hum Hered; 2011; 71(2):113-25. PubMed ID: 21734402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-platform design for next generation genome-wide association studies.
    Sampson JN; Jacobs K; Wang Z; Yeager M; Chanock S; Chatterjee N
    Genet Epidemiol; 2012 May; 36(4):400-8. PubMed ID: 22508365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of empirical Bayes hierarchical modeling for the analysis of genome-wide association study data.
    Heron EA; O'Dushlaine C; Segurado R; Gallagher L; Gill M
    Biostatistics; 2011 Jul; 12(3):445-61. PubMed ID: 21252078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.
    Skol AD; Scott LJ; Abecasis GR; Boehnke M
    Nat Genet; 2006 Feb; 38(2):209-13. PubMed ID: 16415888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project.
    Nannya Y; Taura K; Kurokawa M; Chiba S; Ogawa S
    Hum Mol Genet; 2007 Oct; 16(20):2494-505. PubMed ID: 17666406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal two-stage genotyping designs for genome-wide association scans.
    Wang H; Thomas DC; Pe'er I; Stram DO
    Genet Epidemiol; 2006 May; 30(4):356-68. PubMed ID: 16607626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genome-wide association studies: recent advances and future directions].
    Nakabayashi K; Tajima A; Shirasawa S
    Nihon Rinsho; 2009 Mar; 67(3):469-76. PubMed ID: 19280918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of potential power gain with imputed genotypes in genome-wide association studies.
    Becker T; Flaquer A; Brockschmidt FF; Herold C; Steffens M
    Hum Hered; 2009; 68(1):23-34. PubMed ID: 19339783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility.
    Julià A; Ballina J; Cañete JD; Balsa A; Tornero-Molina J; Naranjo A; Alperi-López M; Erra A; Pascual-Salcedo D; Barceló P; Camps J; Marsal S
    Arthritis Rheum; 2008 Aug; 58(8):2275-86. PubMed ID: 18668548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed two-stage method for detecting interactions in genomewide association studies.
    Zuo Y; Kang G
    J Theor Biol; 2010 Feb; 262(4):576-83. PubMed ID: 19896954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative methods for H1 simulations in genome-wide association studies.
    Perduca V; Sinoquet C; Mourad R; Nuel G
    Hum Hered; 2012; 73(2):95-104. PubMed ID: 22472690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of missing and erroneous genotypes on tagging SNP selection and power of subsequent association tests.
    Liu W; Zhao W; Chase GA
    Hum Hered; 2006; 61(1):31-44. PubMed ID: 16557026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency and power in genetic association studies.
    de Bakker PI; Yelensky R; Pe'er I; Gabriel SB; Daly MJ; Altshuler D
    Nat Genet; 2005 Nov; 37(11):1217-23. PubMed ID: 16244653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-stage extreme phenotype sequencing design for discovering and testing common and rare genetic variants: efficiency and power.
    Kang G; Lin D; Hakonarson H; Chen J
    Hum Hered; 2012; 73(3):139-47. PubMed ID: 22678112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust test for two-stage design in genome-wide association studies.
    Kwak M; Joo J; Zheng G
    Biometrics; 2009 Dec; 65(4):1288-95. PubMed ID: 19432785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical screening method for genetic factors influencing susceptibility to common diseases in a two-stage genome-wide association study.
    Sato Y; Laird N; Suganami H; Hamada C; Niki N; Yoshimura I; Yoshida T
    Stat Appl Genet Mol Biol; 2009; 8():Article 46. PubMed ID: 19954418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disease-associated deletions in case-control studies using SNP genotypes with application to rheumatoid arthritis.
    Wu CC; Shete S; Chen WV; Peng B; Lee AT; Ma J; Gregersen PK; Amos CI
    Hum Genet; 2009 Aug; 126(2):303-15. PubMed ID: 19415332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust joint analysis with data fusion in two-stage quantitative trait genome-wide association studies.
    Pan DD; Xiong WJ; Zhou JY; Pan Y; Zhou GL; Fung WK
    Comput Math Methods Med; 2013; 2013():843563. PubMed ID: 24288575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.